The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan. 1, 2027.
Continue Reading this article here
Centers for Medicare & Medicaid Services extends short-term bridge program for GLP-1 obesity drug coverage
